OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life
Torleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 11
Torleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Assessing developability early in the discovery process for novel biologics
Monica L. Fernández‐Quintero, Anne Ljungars, Franz Waibl, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 50
Monica L. Fernández‐Quintero, Anne Ljungars, Franz Waibl, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 50
Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 35
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 35
Antibody-Drug Conjugates: A promising breakthrough in cancer therapy
Swapnali Parit, Ajit Manchare, Amol D. Gholap, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124211-124211
Closed Access | Times Cited: 15
Swapnali Parit, Ajit Manchare, Amol D. Gholap, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124211-124211
Closed Access | Times Cited: 15
The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement
Maximilian Brinkhaus, Erwin Pannecoucke, Elvera J. van der Kooi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Maximilian Brinkhaus, Erwin Pannecoucke, Elvera J. van der Kooi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
Torleif Tollefsrud Gjølberg, Simone Mester, Gaia Calamera, et al.
BioDrugs (2025)
Open Access
Torleif Tollefsrud Gjølberg, Simone Mester, Gaia Calamera, et al.
BioDrugs (2025)
Open Access
IgG Fab Glycans Hinder FcRn-Mediated Placental Transport
Mikhail Volkov, Maximilian Brinkhaus, Karin A. van Schie, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 2, pp. 158-167
Open Access | Times Cited: 12
Mikhail Volkov, Maximilian Brinkhaus, Karin A. van Schie, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 2, pp. 158-167
Open Access | Times Cited: 12
Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteins
Shufang Liu, Yingyi Li, Zhe Li, et al.
Journal of Pharmacokinetics and Pharmacodynamics (2024) Vol. 51, Iss. 5, pp. 449-476
Closed Access | Times Cited: 2
Shufang Liu, Yingyi Li, Zhe Li, et al.
Journal of Pharmacokinetics and Pharmacodynamics (2024) Vol. 51, Iss. 5, pp. 449-476
Closed Access | Times Cited: 2
Cellular neonatal Fc receptor recycling efficiencies can differentiate target-independent clearance mechanisms of monoclonal antibodies
Mark A. Bryniarski, Md Tariqul Haque Tuhin, Timothy M. Acker, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 9, pp. 2879-2894
Open Access | Times Cited: 2
Mark A. Bryniarski, Md Tariqul Haque Tuhin, Timothy M. Acker, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 9, pp. 2879-2894
Open Access | Times Cited: 2
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
Tolulope A. Aweda, Shih‐Hsun Cheng, Stephen C. Lenhard, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 3, pp. 667-678
Open Access | Times Cited: 10
Tolulope A. Aweda, Shih‐Hsun Cheng, Stephen C. Lenhard, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 3, pp. 667-678
Open Access | Times Cited: 10
Cardiovascular Adverse Events Associated with Tumor Necrosis Factor-Alpha Inhibitors: A Real-World Pharmacovigilance Analysis
Junlong Ma, Jiangfan Cai, Heng Chen, et al.
Journal of Atherosclerosis and Thrombosis (2024)
Open Access | Times Cited: 1
Junlong Ma, Jiangfan Cai, Heng Chen, et al.
Journal of Atherosclerosis and Thrombosis (2024)
Open Access | Times Cited: 1
Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling
Tulika Tulika, Fulgencio Ruso‐Julve, Shirin Ahmadi, et al.
Structure (2024) Vol. 32, Iss. 9, pp. 1404-1418.e7
Open Access | Times Cited: 1
Tulika Tulika, Fulgencio Ruso‐Julve, Shirin Ahmadi, et al.
Structure (2024) Vol. 32, Iss. 9, pp. 1404-1418.e7
Open Access | Times Cited: 1
